European Archives - Page 748 of 996 - European Medical Journal

Considering Patients’ Needs: Action and Reaction of Interleukin-6 Blockade

The objective of the symposium was to explain the mechanism behind IL-6 dysfunction in RA pathophysiology, review novel RA therapies…

Interleukin-23: The Common Link Between the Joint, the Gut, and the Skin?

Prof McGonagle introduced the symposium and briefly described the aims of the meeting.

Protein from a Worm Parasite Could Provide New Treatments for Inflammatory Bowel Diseases

A PROTEIN from a worm parasite could provide the basis for future treatment options for inflammatory bowel diseases, according to researchers at the…

EMJ

Want to Defeat Diabetes? Take Care of Women!

The recently released Eighth Edition of the International Diabetes Federation (IDF) Atlas reported that 425 million adults worldwide have been diagnosed…

EMJ

An Interview with Dr Harry Antoniades at The Liver Day: New Perspectives in Clinical Hepatology 2017

During the event ‘The liver day: New perspectives in clinical hepatology 2017’ on Wednesday 8th November 2017, organised by the Royal Society of Medicine…

New Generation of Remote-Controlled Nanorobots Developed

NANOROBOTS that have the potential to diagnose disease and deliver drugs from within the human body have been created by a team of researchers…

Introducing the European Medical Journal 2.4

United Kingdom, November 30, 2017: The team at the European Medical Journal is proud to present the latest edition of their flagship publication EMJ 2.4.

Potential

Way back at the beginning of the year, when I was asked to create content and a schedule for the Future Leaders blog posts, I decided that I would write…

Cristal Therapeutics Awarded €2.5 Million Horizon 2020 Grant to Advance Its CriPec®-docetaxel Through Phase 2 Trials

Cristal Therapeutics Awarded €2.5 Million Horizon 2020 Grant to Advance Its CriPec®-docetaxel Through Phase 2 Trials

SOTIO Broadens Its Phase II Clinical Trial Program in Ovarian Cancer

Prague, Czech Republic, 28 November, 2017 – SOTIO, a biotechnology company owned by the PPF Group, today announced the enrollment of the first patient…